All in all, our study highlights the distinct profiles of anti-PF4/H antibodies and platelet activation in HIT and VITT, demonstrating the irrelevance of systematically testing anti-PF4/H during COVID-19 or after vaccination in healthy subjects or in SID. This evidence concerns the gene PF4 and COVID-19.